Belt ndi Road: Mgwirizano, Kugwirizana ndi Win-Win
mankhwala

Zogulitsa

Empagliflozin CAS:864070-44-0 Wopanga

Empagliflozin ndi gulu la C-glycosyl lopangidwa ndi zotsalira za beta-glucosyl zomwe zimakhala ndi (4-chloro-3-{4--[(3S)-tetrahydrofuran-3-yloxy]benzyl}gulu la phenyl pa anomeric center. co-transporter 2 inhibitor yomwe imagwiritsidwa ntchito ngati chothandizira pazakudya ndi masewera olimbitsa thupi kuti apititse patsogolo kuwongolera kwa glycemic mwa akuluakulu omwe ali ndi matenda a shuga a 2. Ili ndi gawo ngati protein yonyamula sodium-glucose subtype 2 inhibitor ndi wothandizira wa hypoglycemic. Ndi C-glycosyl pawiri, ether onunkhira, tetrahydrofuryl ether ndi membala wa monochlorobenzenes.


Tsatanetsatane wa Zamalonda

Zogulitsa Tags

Kugwiritsa Ntchito ndi Zotsatira

Empagliflozin ndi buku, lamphamvu komanso losankha SGLT-2 inhibitor, limathandizira kuwongolera glycemic komanso mawonekedwe a metabolic syndrome mu makoswe odwala matenda ashuga. imayambitsa shuga m'magazi kuti itulutsidwe ndi impso ndi kuchotsedwa mumkodzo.Empagliflozin ingayambitse kutaya madzi m'thupi ndi kuchititsa kuchepa kwa kuthamanga kwa magazi, zomwe zimapangitsa odwala omwe ali ndi chizungulire kapena kukomoka komanso kuchepa kwa aimpso.Chiwopsezo cha odwala okalamba, makamaka omwe ali ndi vuto laimpso ndi okodzetsa, akuwoneka kuti ndi okulirapo.FDA imafuna kuti Boehring ndi Eli Lilly azichita maphunziro anayi pambuyo potsatsa malonda: mayeso omaliza omaliza amtima wamtima, mayeso a pharmacokinetics ndi pharmacodynamics, chitetezo cha ana ndi mphamvu. mayesero, kawopsedwe mayeso kwa mankhwala (makamaka zotsatira aimpso ntchito, fupa ndi kukula ndi chitukuko).

Product Chitsanzo

Chithunzi 71(1)
Chithunzi 72(1)

Kulongedza katundu:

Chithunzi 73(1)

Zina Zowonjezera:

Kupanga C23H27ClO7
Kuyesa 99%
Maonekedwe White ufa
CAS No. 864070-44-0
Kulongedza 25KG
Shelf Life zaka 2
Kusungirako Sungani pamalo ozizira ndi owuma
Chitsimikizo ISO.

  • Zam'mbuyo:
  • Ena:

  • Lembani uthenga wanu apa ndikutumiza kwa ife